This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 23-26, 2024
Hynes Convention CenterBoston, USA

Johan Rockberg
Professor at KTH Royal Institute of Technology


Professor in directed evolution and antibody technology at KTH Royal Inst. Technology, Sweden. Director of GeneNova, a center focused on developing platforms for more cost effective, safe and efficacious AAV based gene therapy through interdisciplinary industry and academia collaborations. He is an expert in protein and cell line engineering with 19000 citations and 55+ publications. Co-PI of human protein atlas program cataloging all human proteins. Co-founder five of companies including StrikePharma AB (Uppsala) developing cancer vaccine, Abclon (Seoul, SouthKorea) developing CAR-T and immunotherapy. Elected member of the Swedish Young Academy (SUA) and Royal Academy of Science (KVA) research policy committee.

Agenda Sessions

  • KEYNOTE: Cellular demands of secreted biopharmaceuticals and AAV– how systems and synthetic biology improve quality and titer


At this event